STAT news - Biotech

STAT+: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition

2024-04-28 18:40

STAT+: Bernie Sanders targets ‘outrageously high price’ of Ozempic

2024-04-25 13:48

STAT+: Profiting from ‘legal’ insider trading isn’t always easy

2024-04-25 12:55

STAT+: Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future

2024-04-25 11:01

STAT+: Biogen’s Alzheimer’s drug launch on ‘steady pace’ as logistical hurdles recede

2024-04-24 15:06

STAT+: A spending frenzy on obesity drugs

2024-04-24 14:29

STAT+: New studies suggest GLP-1 health care costs have only begun to climb

2024-04-24 09:30

STAT+: Novo Nordisk’s move to discontinue an insulin leaves patients to ‘pick up the pieces’

2024-04-24 08:30

STAT+: Day One drug for common childhood brain tumor approved by FDA

2024-04-23 18:13

STAT+: Looking for signs of growth in Biogen’s earnings

2024-04-23 13:01

STAT+: Novo Nordisk’s growth plan

2024-04-22 14:09

Listen: A new obesity startup, an acquisition gone wrong, & the future of Teladoc

2024-04-18 19:26

STAT+: Listen: A new obesity startup, an acquisition gone wrong, & the future of Teladoc

2024-04-18 19:26

STAT+: Taking stock of the frenzied push into autoimmune disease

2024-04-18 13:13

STAT+: 23andme CEO Anne Wojcicki moves to take company private

2024-04-18 11:58

STAT+: Cancer vaccine startup launches with $54 million, Spark veteran as CEO

2024-04-18 11:00

STAT+: ARCH, Medicines Co. veterans raise $290 million for in-licensed obesity drugs

2024-04-18 11:00

STAT+: Cerevel drug for Parkinson’s disease improved symptom control in trial

2024-04-18 10:30

Amylyx’s Relvyvrio data was, as promised, disappointing

2024-04-17 14:27

STAT+: Amylyx’s Relvyvrio data was, as promised, disappointing

2024-04-17 14:27

STAT+: Eli Lilly’s Zepbound eases obstructive sleep apnea in trials

2024-04-17 10:15

Biohaven’s data delay degrades stock price

2024-04-16 13:45

STAT+: Biohaven’s data delay degrades stock price

2024-04-16 13:45

STAT+: Intra-Cellular reports positive results in depression study aimed at expanding use of antipsychotic medicine

2024-04-16 11:39

A two-decade bet on Seagen pays off

2024-04-15 14:08

STAT+: A two-decade bet on Seagen pays off

2024-04-15 14:08

STAT+: Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition

2024-04-15 12:19

STAT+: Can investing in infectious disease pay off? Vir Biotechnology’s tightrope walk shows it’s a struggle

2024-04-15 08:30

STAT+: What about the company Vertex didn’t buy?

2024-04-12 13:39

What about the company Vertex didn’t buy?

2024-04-12 13:39

STAT+: The inside story of Enhertu’s pan-tumor approval

2024-04-11 13:56

Gas prices are hurting biotech

2024-04-11 13:40

STAT+: Gas prices are hurting biotech

2024-04-11 13:40

STAT+: Medicare expects to spend $3.5 billion on new Alzheimer’s drug in 2025

2024-04-11 08:30

STAT+: Vertex to buy Alpine Immune Sciences for $4.9 billion

2024-04-10 20:27

AskBio CSO steps down, has new project in stealth mode

2024-04-10 13:13

STAT+: AskBio CSO steps down, has new project in stealth mode

2024-04-10 13:13

STAT+: Cancer vaccines gain momentum, after years of disappointing results

2024-04-10 08:30

Pfizer’s plot to win the RSV vaccine race

2024-04-09 13:05

STAT+: Pfizer’s plot to win the RSV vaccine race

2024-04-09 13:05

STAT+: Biotech startups post strongest financing numbers in two years

2024-04-09 12:42

STAT+: Big biotech names roll out Seaport Therapeutics, as interest in neuropsychiatric drugs swells

2024-04-09 08:27

STAT+: The latest updates on cancer research from the weekend

2024-04-08 13:34

The latest updates on cancer research from the weekend

2024-04-08 13:34

STAT+: WHO scientists question Grail’s plan for evaluating its multi-cancer Galleri blood test

2024-04-07 22:30

STAT+: Alnylam’s twice-a-year drug lowered blood pressure when combined with common pills

2024-04-07 12:00

Sanofi resolves most Zantac litigation

2024-04-05 13:14

STAT+: Sanofi resolves most Zantac litigation

2024-04-05 13:14

STAT+: Boehringer Ingelheim layoffs are a sign of dysfunctional Humira biosimilar market

2024-04-04 22:17

STAT+: Weed for weight loss, and more from Biotech Land

2024-04-04 16:07

How resurrecting extinct species might impact medicine

2024-04-04 13:55

STAT+: How resurrecting extinct species might impact medicine

2024-04-04 13:55

STAT+: Matt & Adam’s Take: Amylyx did the right thing by withdrawing its ALS drug. That’s rare and worthy of praise

2024-04-04 13:49

STAT+: Amylyx to pull ALS drug from market, cut 70% of staff

2024-04-04 11:40

Opinion: For national security, the U.S. must maintain its biotech dominance

2024-04-04 08:30

Opinion: STAT+: For national security, the U.S. must maintain its biotech dominance

2024-04-04 08:30

Parkinson’s disease may be helped by GLP-1 drug, new study finds

2024-04-03 21:00

STAT+: Parkinson’s disease may be helped by GLP-1 drug, new study finds

2024-04-03 21:00

STAT+: Early data from rare-disease trial put spotlight on Moderna’s efforts to turn mRNA into medicines

2024-04-03 15:00

New data on liquid biopsy for colorectal cancer detection still underwhelms

2024-04-03 13:29

STAT+: New data on liquid biopsy for colorectal cancer detection still underwhelms

2024-04-03 13:29

STAT+: Investors funnel $275 million into Paragon Therapeutics spinout

2024-04-03 12:23

STAT+: As AI proliferates, biopharma companies seek to harness it in clinical trials

2024-04-03 10:00

STAT+: Genmab to buy ProfoundBio for $1.8 billion, the latest deal focused on targeted chemotherapies

2024-04-03 06:51

STAT+: Roivant CEO: New deals could ‘materialize later this year’

2024-04-02 16:24

Lawmakers want to add more Chinese biotechs to defense list

2024-04-02 13:38

STAT+: Lawmakers want to add more Chinese biotechs to defense list

2024-04-02 13:38

STAT+: Gritstone Bio says personalized cancer vaccine falls short in key trial

2024-04-02 12:52

STAT+: Roivant autoimmune drug succeeds in eye condition; company to buy back $1.5 billion in stock

2024-04-02 11:00

STAT+: Verve Therapeutics ‘pauses’ tests of its gene editor for heart disease and prioritizes a backup treatment

2024-04-02 11:00

STAT+: The biotech scoreboard for the second quarter: 32 stock-moving events to watch

2024-04-02 08:30

Aardvark Therapeutics gearing up for $200 million IPO

2024-04-01 13:22

STAT+: Aardvark Therapeutics gearing up for $200 million IPO

2024-04-01 13:22

STAT+: Critics say U.K. decision on ALS drug could have ‘chilling effect’ on access to new genetic medicines

2024-04-01 08:30

STAT+: What’s Congress going to do with WuXi?

2024-03-29 13:03

What’s Congress going to do with WuXi?

2024-03-29 13:03

How GLP-1’s moved from research labs to national TV

2024-03-28 12:13

STAT+: How GLP-1’s moved from research labs to national TV

2024-03-28 12:13

STAT+: Why the world’s most expensive drug might not be all that overpriced

2024-03-28 08:30

Brazil’s plan for low-cost CAR-Ts

2024-03-27 13:25

STAT+: Brazil’s plan for low-cost CAR-Ts

2024-03-27 13:25

STAT+: Roche subsidiary Foundation Medicine opens new headquarters in Boston

2024-03-26 18:01

Merck’s next big thing is (probably) on the way

2024-03-26 13:13

STAT+: Merck’s next big thing is (probably) on the way

2024-03-26 13:13

STAT+: Viking Therapeutics to move its oral obesity drug into Phase 2 study after early success

2024-03-26 11:55

STAT+: Vertex Pharmaceuticals is considering relocating its headquarters

2024-03-25 19:59

How will the Supreme Court’s mifepristone decision impact biopharma?

2024-03-25 13:41

SCOTUS’ abortion pill mifepristone case is really about the FDA

2024-03-25 08:30

STAT+: SCOTUS’ abortion pill mifepristone case is really about the FDA

2024-03-25 08:30

STAT+: Patient advocates clash over wisdom of ‘approving drugs faster and faster’

2024-03-25 08:30

STAT+: During the pandemic, were great vaccines bad business? A company-by-company review

2024-03-25 08:30

FDA approves new drug to protect immune compromised from Covid-19

2024-03-22 21:57

FDA authorizes new drug to protect immune compromised from Covid-19

2024-03-22 21:57

STAT+: How biotech investors spot opportunity when stocks are down — and up

2024-03-22 18:40

EU adviser says Illumina merger was not problematic

2024-03-22 13:07

STAT+: EU adviser says Illumina merger was not problematic

2024-03-22 13:07

STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint

2024-03-22 08:30

STAT+: Regeneron’s plot to ‘cure’ allergies

2024-03-21 18:02

Getting CRISPR treatments to patients remains a major challenge. Could lab-developed tests help?

2024-03-21 17:42

STAT+: Getting CRISPR treatments to patients remains a major challenge. Could lab-developed tests help?

2024-03-21 17:42

STAT+: Feng Zhang suggests Editas didn’t move quickly enough to find product targets

2024-03-21 15:24

STAT+: Gene-edited pig kidney transplanted into a living patient for the first time

2024-03-21 13:38

BioNTech is having its Pfizer moment

2024-03-21 12:48

STAT+: BioNTech is having its Pfizer moment

2024-03-21 12:48

STAT+: Prometheus team launches new startup with $400 million to tackle immune-driven disorders

2024-03-21 11:00

STAT+: A preview of Intra-Cellular Therapies’ depression drug, and sizing up the MASH opportunity

2024-03-21 08:30

Novo is building a really big computer

2024-03-20 12:52

STAT+: Novo is building a really big computer

2024-03-20 12:52

STAT+: Immuno-oncology startup launches with $150 million, ex-Surface, Bluebird exec as CEO

2024-03-20 11:00

STAT+: New gene therapy, to be priced at $4.25 million, has already transformed children’s lives

2024-03-20 11:00

STAT+: Wegovy and Zepbound get primetime treatment

2024-03-19 13:53

Wegovy and Zepbound get primetime treatment

2024-03-19 13:53

STAT+: FDA approves first gene therapy for a fatal neuron disease in children

2024-03-18 19:14

STAT+: FDA approves first gene therapy for fatal neuron disease in children

2024-03-18 19:14

Contineum Therapeutics files for IPO

2024-03-18 13:36

STAT+: Contineum Therapeutics files for IPO

2024-03-18 13:36

STAT+: I was wrong about Geron’s blood cancer drug. Now, is it a takeover target?

2024-03-18 13:03

STAT+: The Boston area built a ton of lab space. Now many of those buildings are opening empty

2024-03-16 22:32

STAT+: FDA advisers back CAR-T therapies in blood cancer, despite safety concerns

2024-03-15 21:22

STAT+: What happens when an approved drug doesn’t work?

2024-03-15 13:09

What happens when an approved drug doesn’t work?

2024-03-15 13:09

STAT+: Madrigal wins first U.S. approval for drug to treat liver disease MASH

2024-03-14 20:23

Is CAR-T safe for early-stage patients?

2024-03-14 13:27

STAT+: Is CAR-T safe for early-stage patients?

2024-03-14 13:27

STAT+: Vertex hits speed bump in getting CRISPR sickle cell therapy covered in U.K.

2024-03-14 11:20

STAT+: Argenx readies another blockbuster opportunity with its antibody drug

2024-03-14 08:30

STAT+: BIO severs ties with WuXi in the face of U.S. government concerns over China

2024-03-13 22:53

STAT+: Small studies offer hope CAR-T can fight an aggressive brain cancer

2024-03-13 21:00

Geron’s resurgence might have been short-lived

2024-03-13 13:11

STAT+: Geron’s resurgence might have been short-lived

2024-03-13 13:11

STAT+: Hemophilia gene therapies arrived after 40 years of struggle. Where are the patients?

2024-03-13 08:30

STAT+: When did Wall Street sour on Lilly’s Alzheimer’s drug?

2024-03-12 13:21

When did Wall Street sour on Lilly’s Alzheimer’s drug?

2024-03-12 13:21

STAT+: First medicine developed to treat MASH expected to be approved soon

2024-03-12 08:30

STAT+: Acadia’s Nuplazid fails as treatment for schizophrenia in Phase 3 study

2024-03-11 20:57

Preventing the weaponization of AI-designed proteins

2024-03-11 12:51

STAT+: Preventing the weaponization of AI-designed proteins

2024-03-11 12:51

STAT+: Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next

2024-03-08 20:22

Eli Lilly’s anti-vanity ad campaign for Oscars

2024-03-08 14:23

STAT+: Eli Lilly’s anti-vanity ad campaign for Oscars

2024-03-08 14:23

STAT+: In surprise move, FDA calls for advisory committee on Lilly’s Alzheimer’s drug

2024-03-08 12:02

STAT+: In stunning outcome, Amylyx’s ALS drug fails large clinical trial

2024-03-08 12:00

STAT+: Biden’s SOTU highlights pharma’s biggest political problem: It is terrifyingly, awfully alone

2024-03-08 09:30

Banning WuXi is more complicated than it might sound

2024-03-07 14:30

STAT+: Banning WuXi is more complicated than it might sound

2024-03-07 14:30

STAT+: Novo Nordisk’s obesity pill bests Wegovy in early trial

2024-03-07 13:00

STAT+: A deep dive into Applied Therapeutics’ data, and questions on Cassava’s erased data

2024-03-07 09:30

Bayer’s not breaking up. At least not yet

2024-03-06 14:34

STAT+: Bayer’s not breaking up. At least not yet

2024-03-06 14:34

Startup Alumis raises $259 million as it prepares for psoriasis trial

2024-03-06 13:00

STAT+: Startup Alumis raises $259 million as it prepares for psoriasis trial

2024-03-06 13:00

STAT+: Where’s Lilly’s Alzheimer’s approval?

2024-03-05 14:30

Where’s Lilly’s Alzheimer’s approval?

2024-03-05 14:30

STAT+: ‘It’s a nightmare’: One of the most common children’s asthma meds is no longer available, leaving families scrambling

2024-03-04 17:37

STAT+: Massachusetts lawmakers consider $1 billion proposal to bolster region’s life science leadership

2024-03-04 16:31

Serum Institute of India wants government HPV contract

2024-03-04 14:26

STAT+: Serum Institute of India wants government HPV contract

2024-03-04 14:26

STAT+: Longer treatment gave better liver outcomes for MASH patients, Akero drug study shows

2024-03-04 11:00

Despite good data, Ironwood’s shares plummet 

2024-03-01 13:56

STAT+: Despite good data, Ironwood’s shares plummet 

2024-03-01 13:56

STAT+: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships

2024-03-01 12:00

STAT+: Here are the cancer drugs Pfizer thinks could reignite investors’ interest

2024-03-01 00:19

STAT+: What does America’s crackdown on Chinese firms mean for the U.S. biotech sector?

2024-02-29 19:54

STAT+: The next act for a biotech rainmaker

2024-02-29 14:54

The next act for a biotech rainmaker

2024-02-29 14:54

STAT+: This chemist’s last startup sold for $4 billion. Now investors have poured $173 million into her next act

2024-02-29 13:00

STAT+: Biotech launches with $82 million for Parkinson’s cell therapy

2024-02-29 12:00

Q&A: A biotech VC leader shares her next big bets

2024-02-29 09:30

STAT+: Q&A: A biotech VC leader shares her next big bets

2024-02-29 09:30

STAT+: Pfizer is about to make a big push in cancer. Will investors listen?

2024-02-29 09:30

STAT+: An inside look at PIPEs, the financing trend that has biotech abuzz

2024-02-29 09:30

Beam is trading like it’s 2021

2024-02-28 14:59

STAT+: Beam is trading like it’s 2021

2024-02-28 14:59

STAT+: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

2024-02-28 09:30

GSK pill works in uncomplicated gonorrhea

2024-02-27 14:23

STAT+: GSK pill works in uncomplicated gonorrhea

2024-02-27 14:23

STAT+: Viking Therapeutics obesity drug hits target in key study, raising hopes for a competitor to existing medicines

2024-02-27 12:57

STAT+: The FDA isn’t afraid to yank a disappointing drug

2024-02-26 14:25

The FDA isn’t afraid to yank a disappointing drug

2024-02-26 14:25

STAT+: Liver disease MASH is next target for obesity drugs in development

2024-02-26 09:30

STAT+: Ocular Therapeutix moves in the right direction, and Alnylam tries to calm some nerves

2024-02-23 14:24

STAT+: What do CEOs owe the world?

2024-02-23 14:06

What do CEOs owe the world?

2024-02-23 14:06

STAT+: Annovis Bio delivers candor on its Parkinson’s study, even if it doesn’t inspire much confidence

2024-02-23 12:41

Novavax’s money is going in the wrong direction

2024-02-22 14:34

STAT+: Novavax’s money is going in the wrong direction

2024-02-22 14:34

STAT+: Scientists take a (small) step toward universal antivenom

2024-02-21 19:00

Actually Wegovy is good for dialysis companies, dialysis provider says

2024-02-21 14:08

STAT+: Actually Wegovy is good for dialysis companies, dialysis provider says

2024-02-21 14:08

STAT+: Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

2024-02-20 18:23

STAT+: AbbVie CEO Gonzalez to step down after a decade fiercely defending its top seller, Humira

2024-02-20 17:14

Bayer, short on cash, reaches into shareholders’ pockets

2024-02-20 14:36

STAT+: Bayer, short on cash, reaches into shareholders’ pockets

2024-02-20 14:36

STAT+: In ‘major milestone,’ FDA approves first cell therapy for solid tumors

2024-02-17 00:24

STAT+: Flagship Pioneering startup lays off a third of staff

2024-02-16 19:56

STAT+: Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

2024-02-16 16:27

Alnylam thickened the plot

2024-02-16 14:01

STAT+: Alnylam thickened the plot

2024-02-16 14:01

STAT+: For unlucky mountaineers, tundra explorers and the unhoused, a new drug could avert the ravages of frostbite

2024-02-16 09:30

STAT+: For unlucky mountaineers, tundra explorers, and the unhoused, a new drug could avert the ravages of frostbite

2024-02-16 09:30

Pharma’s contractors might finally be on the rebound

2024-02-15 14:45

STAT+: Pharma’s contractors might finally be on the rebound

2024-02-15 14:45

STAT+: Gaming Amylyx stock reactions to the next ALS drug test, and a chat with CRISPR’s CEO about a new investor

2024-02-15 09:30

STAT+: The Jewish American and Palestinian American scientists who’ve been partnering for 14 years on science’s toughest challenges

2024-02-14 21:06

Replicate’s srRNA rabies vaccine effective in Phase 1

2024-02-14 13:32

STAT+: Replicate’s srRNA rabies vaccine effective in Phase 1

2024-02-14 13:32

STAT+: Biotech launches with $135 million for Vertex-competing pain medicine

2024-02-14 10:00

STAT+: Biogen Alzheimer’s drug launch off to slow start

2024-02-13 19:54

STAT+: The need to know biotech news stories today

2024-02-13 14:42

The need to know biotech news stories today

2024-02-13 14:42

STAT+: Startup BioAge raises $170 million Series D for Zepbound combination therapy

2024-02-13 13:00

STAT+: KalVista pill reduces swelling symptoms caused by genetic disease, achieving goal of late-stage study

2024-02-13 11:30

STAT+: Gilead to acquire CymaBay for $4.3 billion, adding new treatment for liver disease

2024-02-12 14:45

Psychedelic investment continues to ramp up

2024-02-12 14:38

STAT+: Psychedelic investment continues to ramp up

2024-02-12 14:38

Does Moderna’s RSV vaccine lose efficacy faster than others?

2024-02-09 14:38

STAT+: Does Moderna’s RSV vaccine lose efficacy faster than others?

2024-02-09 14:38

STAT+: A looming cancer vaccine test for Gritstone Bio, and pushback about Novartis-MorphoSys

2024-02-08 16:40

Gilead sours on the ‘don’t eat me’ business

2024-02-08 14:50

STAT+: Gilead sours on the ‘don’t eat me’ business

2024-02-08 14:50

STAT+: A gene therapy designed to heal skin wounds helped preserve a boy’s vision

2024-02-07 22:00

STAT+: The GLP-1 panic is alive and well

2024-02-07 14:41

The GLP-1 panic is alive and well

2024-02-07 14:41

STAT+: RayzeBio co-founder, industry veterans launch new biotech VC with $310 million

2024-02-07 11:00

STAT+: Why Eli Lilly’s earnings didn’t quite live up to the hype

2024-02-06 21:11

STAT+: Why Novartis is going to walk away from its acquisition of MorphoSys

2024-02-06 16:44

STAT+: Vertex still knows how to do what it does best

2024-02-06 14:46

Vertex still knows how to do what it does best

2024-02-06 14:46

STAT+: Eli Lilly reports tirzepatide MASH success during Q4 earnings

2024-02-06 13:05

STAT+: Novartis to buy German biotech MorphoSys for $2.9 billion

2024-02-05 22:21

STAT+: Novo’s Catalent deal is great for GLP-1s. But what about drug manufacturing?

2024-02-05 18:49

Regeneron is interested in obesity treatments that combat muscle loss

2024-02-05 14:35

STAT+: Regeneron is interested in obesity treatments that combat muscle loss

2024-02-05 14:35

STAT+: ARCH Venture Partners is raising $3 billion for a life sciences fund

2024-02-02 21:49

STAT+: The lessons of Aduhelm, Biogen’s Alzheimer’s drug that was not to be

2024-02-02 21:07

STAT+: What makes a drug a blockbuster — or a cautionary tale?

2024-02-02 14:12

What makes a drug a blockbuster — or a cautionary tale?

2024-02-02 14:12

STAT+: Raleigh-Durham challenges Boston as biomanufacturing hub of the future

2024-02-01 15:46

Novavax is on thin ice, and the latest update isn’t exactly encouraging

2024-02-01 14:34

STAT+: Can gene therapies make for a profitable business? Keep your eye on Bluebird Bio

2024-02-01 09:30

STAT+: Obscure vertigo drug could bring rare hope for patients with devastating neuron disease

2024-01-31 22:00

STAT+: Judge skeptical of arguments against Medicare drug price negotiation

2024-01-31 20:52

Pfizer’s reset year starts with a little profit

2024-01-31 14:36

STAT+: Pfizer’s reset year starts with a little profit

2024-01-31 14:36

STAT+: Years after a polarizing approval, Biogen walks away from Aduhelm

2024-01-31 12:40

STAT+: Vertex pain drug results met with measured optimism — and questions — by observers and experts

2024-01-30 22:11

STAT+: Here are the new hotspots for Boston-area biotech

2024-01-30 15:44

How an immunological Trojan horse could treat disease

2024-01-30 14:45

STAT+: How an immunological Trojan horse could treat disease

2024-01-30 14:45

STAT+: Vertex’s closely watched pain relief drug succeeds in late-stage trials — with a catch

2024-01-30 11:30

STAT+: Cour Pharmaceuticals, a biotech taking aim at autoimmune diseases, raises $105 million

2024-01-30 11:00

STAT+: Ultima Genomics launching high-end DNA sequencers that can read genome for $100

2024-01-30 11:00

23andMe breach targeted Chinese, Jewish populations

2024-01-29 14:30

STAT+: 23andMe breach targeted Chinese, Jewish populations

2024-01-29 14:30

STAT+: Vaccines save lives and generate profits. Why is investment lagging?

2024-01-26 17:39

Eli Lilly overtakes Tesla in market value

2024-01-26 14:29

STAT+: Eli Lilly overtakes Tesla in market value

2024-01-26 14:29

Another step toward new drugs for Parkinson’s

2024-01-25 14:29

STAT+: Another step toward new drugs for Parkinson’s

2024-01-25 14:29

STAT+: As biotech VCs struggle to raise money, some debate whether the worst is over

2024-01-25 11:00

STAT+: What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s surprising rise

2024-01-25 09:30

Lilly’s gene therapy restores hearing in an 11-year-old, paving way for more treatment

2024-01-24 14:06

STAT+: Lilly’s gene therapy restores hearing in an 11-year-old, paving way for more treatment

2024-01-24 14:06

Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect

2024-01-23 14:41

STAT+: Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect

2024-01-23 14:41

Investigators fault Lilly plant for manufacturing issues

2024-01-22 14:04

STAT+: Investigators fault Lilly plant for manufacturing issues

2024-01-22 14:04

STAT+: Gilead’s Trodelvy fails in lung cancer and raises new questions on antibody drug conjugate drugs

2024-01-22 13:30

The Senate health committee looks into its first subpoena in 40 years

2024-01-19 14:18

STAT+: CRISPR-edited pig liver from eGenesis passes first test in brain-dead human, researchers say

2024-01-18 17:00

STAT+: The XBI comedown after JPM

2024-01-18 14:33

The XBI comedown after JPM

2024-01-18 14:33

STAT+: The big any-day-now biotech news we’re keeping an eye on

2024-01-17 14:23

The big any-day-now biotech news we’re keeping an eye on

2024-01-17 14:23

STAT+: At health care’s biggest investor conference, AI’s high hopes collided with skepticism

2024-01-17 09:30

STAT+: Dewpoint Therapeutics cuts 15% of staff, acknowledges Merck, Pfizer broke off partnerships over buzzy science

2024-01-16 21:33

STAT+: FDA expands approval of CRISPR-based medicine to treat beta thalassemia

2024-01-16 19:41

STAT+: The four biotech stories you need to read this morning

2024-01-16 14:07

The four biotech stories you need to read this morning

2024-01-16 14:07

STAT+: For-profit biomedical institute, backed by billionaires, launches in Cambridge to speed drug discovery

2024-01-13 15:17

Novartis reportedly decides to pass on Cytokinetics

2024-01-12 22:54

STAT+: Novartis reportedly decides to pass on Cytokinetics

2024-01-12 22:54

STAT+: STAT Virtual Event | 2024 JPM Recap, Live!

2024-01-12 08:00

STAT Virtual Event | 2024 JPM Recap, Live!

2024-01-12 08:00

STAT+: The highs — and lows — of JPM 2024 you should pay attention to

2024-01-11 23:57

The highs — and lows — of JPM 2024 you should pay attention to

2024-01-11 23:57

STAT+: A biotech reporter’s notebook: Sunshine rains down on San Francisco

2024-01-11 09:30

JPM Day 3 had a cautiously optimistic outlook

2024-01-10 22:20

STAT+: JPM Day 3 had a cautiously optimistic outlook

2024-01-10 22:20

STAT+: At JPM, Verve details plot to take genome editing mainstream

2024-01-10 20:49

JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far

2024-01-09 23:03

STAT+: JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far

2024-01-09 23:03

STAT+: FDA’s Peter Marks seems inclined to grant full approval to Sarepta’s Duchenne gene therapy

2024-01-09 16:28

STAT+: Nvidia says a biological revolution is happening now. But is it?

2024-01-09 13:22

STAT+: JPM 2024: FogPharma’s new CEO, Mathai Mamman, unveils ‘contrarian’ plan in oncology

2024-01-09 12:49

STAT+: JPM 2024: FogPharma’s new CEO, Mathai Mammen, unveils ‘contrarian’ plan in oncology

2024-01-09 12:49

STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution

2024-01-09 12:30

STAT+: The Afghan father aided U.S. soldiers. Now Texas Medicaid won’t pay for his son’s gene therapy

2024-01-09 09:30

The Afghan father aided U.S. soldiers. Now Texas Medicaid won’t pay for his son’s gene therapy

2024-01-09 09:30

STAT+: GSK to acquire Aiolos Bio in $1.4 billion deal, picking up an experimental asthma drug

2024-01-09 07:53